Beverly Hills Weight Loss & WellnessŪ, a wholly-owned subsidiary of Weight Loss Forever
International (OTC Bulletin Board: WLFI - News), has entered an agreement with ProMedis, a division of Jamieson Laboratories, to market its line of health and food supplements. ProMedis, whose formulas have approval from the U.S. Food & Drug Administration, develops products for weight management and bariatrics.
"The ProMedis line of food supplements is a high-profile addition to the quality products we already offer," explained Michael D'Apolito, President of Beverly Hills. "Our major competitor doesn't offer FDA-approved health food supplements, so obviously we see this as an important marketing niche to take advantage of." ProMedis will be promoted and priced as top-of-the-line premium products, and will soon be included on the company's new e-commerce website at Beverly Hills Weight Loss.
The ProMedis family of products consists of functional foods, such as soups, puddings, beverages, health bars and snacks hallmarked by peptide and protein formulas that address obesity. ProMedis company spokeswoman Stephanie Blok explained, "Consumers want a variety of tasty choices in their health supplements. Consumers get bored eating the same supplements over and over. Variety keeps up their interest in staying on the plan."
Established in 1922, Jamieson Laboratories is Canada's largest manufacturer and distributor of advanced natural health-care products. The company is a world leader in the vitamin and nutrition industry, exporting to over 30 countries, including the USA, China, Japan, Hong Kong, Korea and Singapore.
About WLFI
Weight Loss Forever International is a Franchise Management Company currently operating 44 clinics under two brands, Weight Loss ForeverŪ and Beverly Hills Weight Loss & WellnessŪ. WLFI continues to implement an expansion strategy based on six areas: franchising, master area developers, co-venturing, e-commerce promotion and marketing, acquisitions and increasing clinic revenues.
The expansion of the company product line is part of the 2004 master plan for increasing clinic and Internet sales revenues.
This release may contain forward-looking statements that involve risks and uncertainties, including without limitation, acceptance of the company's products, increased levels of competition, product and technological changes, the company's dependence upon financing and third-party suppliers and other risks detailed from time to time in the company's federal filings, annual report, offering memorandum or prospectus. Specifications are subject to change without notice.
